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Abstract
Background: Alcohol makes an important contribution to premature mortality in many countries in Eastern
Europe, including Estonia. However, the full extent of its impact, and the mechanisms underlying it, are challenging
issues to research. We describe the design and initial findings of a study aimed at investigating the association of
alcohol with mortality in a large series of forensic autopsies of working-age men in Estonia.
Methods: 1299 male deaths aged 25-54 years were subject to forensic autopsy in 2008-2009. The routine autopsy
protocol was augmented by a more systematic inspection of organs, drug testing, assay of liver enzymes and
novel biomarkers of alcohol consumption (EtG, EtS and PEth), together with proxy interviews with next of kin for
deaths among men who lived in or close to a major town.
Results: 595 augmented autopsies were performed. Of these, 66% were from external causes (26% suicide, 25%
poisoning). 17% were attributed to circulatory system diseases and 7% to alcoholic liver disease. Blood alcohol
concentrations (BAC) of ≥ 0.2 mg/g were found for 55% of deaths. Interviews were conducted with proxy informants
for 61% of the subjects who had resided in towns. Of these, 28% were reported in the previous year to have been daily
or almost daily drinkers and 10% had drunk non-beverage alcohols. Blood ethanol and the liver enzyme GGT were only
associated with daily drinking. However, the novel biomarkers showed a more graded response with recent
consumption. In contrast, the liver enzymes AST and ALT were largely uninformative because of post-mortem changes.
The presence of extremely high PEth concentrations in some samples also suggested post-mortem formation.
Conclusion: We have shown the feasibility of deploying an extended research protocol within the setting of
routine forensic autopsies that offer scope to deepen our understanding of the alcohol-related burden of
premature mortality. The most unique feature of the study is the information on a wide range of informative
alcohol biomarkers, several of which have not been used previously in this sort of post-mortem research study. We
have demonstrated, for the first time, the epidemiological value and validity of these novel alcohol biomarkers in
post-mortem samples.
Background
Estonia is the most northerly of the three Baltic States,
with a high burden of premature mortality, especially
among men. In 2008, male life expectancy was only 68.7
years compared to the European Union average of 76.3
[1]. This gap is due, largely, to excess deaths among
men of working age. Heavy alcohol consumption has
been implicated as a major cause, with high levels of
hazardous drinking in the population [2]. The amount
of pure alcohol consumed per person in 2008 was 12.1 l
[3]. Between 1994 and 2006, the proportion of men
aged 25-64 years drinking more than 280 g equivalent
of pure alcohol per week increased from 9.1% to 16.2%
[4]. Non-beverage ethanol containing substances not
intended for consumption (such as eau de colognes and
medicines), that have been implicated in the high
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burden of premature death in neighbouring Russia [5,6],
are also consumed in Estonia [7] and are widely avail-
able in parts of the capital, Tallinn [8].
Mortality from a range of conditions such as cirrhosis
of the liver are known to be strongly linked in a dose-
response fashion to alcohol intake [9].
The impact of drinking on mortality from cardiovas-
cular disease does, however, remain controversial, parti-
cularly whether heavy and/or episodic drinking is a risk
factor for deaths from ischaemic heart disease and, if so,
what the mechanisms may be [10,11]. A recent study in
Russia suggested that heavy consumption of spirits may
be associated with fatal non-atherosclerotic damage to
the heart (including frank cardiomyopathy), misclassified
as ischaemic heart disease [12]. Further investigation of
this hypothesis is a priority given the notably high levels
of cardiovascular mortality in Estonia. In 2008, the age
standardised death rate (age 0-64) from diseases of the
circulatory system in Estonia was 195 per 100,000
(male) and 49 per 100,000 (female), compared with 76
and 19, respectively, in neighbouring Finland and 45
and 13, respectively, in Spain, one of the European
countries with the lowest rates [1]. Similar levels of
excess mortality are seen in other former-Soviet coun-
tries, which also exhibit particularly harmful patterns of
alcohol consumption [2].
Researching the scale and nature of alcohol-related
harm to health in populations characterised by episodic
heavy drinking is challenging [13]. The classic cohort
study, in which baseline alcohol drinking is related to
deaths ascertained over an extended follow-up period of
years or even decades, is not well suited to detecting
acute alcohol-related deaths such as sudden cardiac
death that may be precipitated by an episode of heavy
drinking. While some alcohol-related deaths may be the
end result of the cumulative effects of a long period of
hazardous drinking, for others it may be the result of a
relatively short period of very intense drinking. Many epi-
demiological studies of this topic also suffer from selec-
tion bias in recruitment and follow-up [14]. In addition,
the heaviest drinkers are often socially marginalised and
comprise a hard to reach population who are difficult to
recruit and follow-up [15]. Finally, the selection of under-
lying cause of death when alcohol may be involved is a
difficult issue, being potentially biased by cultural factors
as well as having an arbitrary aspect due to the frequent
presence of multiple alcohol-induced pathologies. To this
extent, cause of death from the death certificate provides
a very partial basis for ascertaining the full extent of the
impact of alcohol on potentially fatal pathologies.
Given these difficulties triangulating data from several
different sources and study designs may be the optimal
strategy. While each has its problems and limitations,
used in combination, they may provide important
insights. A study of deaths subject to forensic autopsy
provides one such source that has not been adequately
exploited in Estonia or neighbouring countries. In this
paper, we describe the design and first results of a
research study of working age men subject to forensic
autopsy in Estonia 2008-2009, with special emphasis on
the behaviour of novel alcohol biomarkers and their
relationship to proxy reports of drinking behaviour
among the deceased.
Methods/Design
The Estonian Forensic Study of Alcohol and Premature
Death was based on deaths subject to autopsy by the
Estonian forensic service. Its aims were to:
1 assess the prevalence of pathological and biomar-
ker evidence of alcohol-induced damage and high
levels of alcohol consumption in the days immedi-
ately prior to death;
2 investigate how far alcohol biomarkers and specific
pathologies present at death are related to proxy
reports of hazardous drinking in the deceased;
3 ascertain the potential contribution of alcohol con-
sumption to death from a range of causes including
sudden cardiac death and other cardiovascular
disease.
The substantive results reported in this paper focus on
the first two aims, i.e. the levels of novel alcohol bio-
markers and the relationship between such biomarkers
and reported drinking behaviours.
Forensic autopsy in Estonia
Today, the forensic science service in Estonia is
equipped to standards comparable with the rest of Wes-
tern Europe, having undergone extensive modernisation
since independence in 1991 following the collapse of the
Soviet Union. Forensic autopsies are carried out in one
of four Regional Forensic Departments belonging to the
Estonian Forensic Science Institute. In Estonia a forensic
medical autopsy is conducted in one of four circum-
stances: if there is evidence of a crime; where death
appears to be caused by external factors (injury, poison-
ing or violence) but no crime is suspected; where the
state of the body makes it impossible to assign a cause
from external inspection; or where the identity of the
deceased is unknown [16]. While such deaths comprise
only a small (14%) and selective fraction of all deaths in
Estonia in 2008-2009, they include a substantial propor-
tion of those dying from acute effects of alcohol con-
sumption (including all deaths attributable to alcohol
poisoning, injuries and violence), as well as those from
the marginalised social groups who are often underre-
presented in other study designs.
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Study protocol
The protocol was developed drawing on our extensive
experience as either forensic specialists or researchers
investigating the link between alcohol and mortality in
Russia. In the design stage, we undertook a review of
the literature and also had extensive discussions with
other colleagues conducting routine forensic autopsies
in Estonia. The protocol went beyond usual forensic
practice in a number of respects:
1. It was designed to record in more detail than
usual the presence or absence of pathologies, with
particular emphasis upon minor pathologies indica-
tive of alcohol-related damage but may not have
been directed implicated as a cause of death.
2. In addition to the routine measurement of blood
and urine ethanol concentrations we assayed levels
of liver enzymes, checked for the presence of a
range of drugs regardless of cause of death, and ana-
lysed concentrations of alcohol biomarkers in blood
and urine;
3. For men who lived in or near main cities, we
endeavoured to interview relatives or friends of the
deceased man to obtain information about their cir-
cumstances and drinking behaviour.
Pilot study
In September 2007, a pilot study to assess the feasibility
of using the enhanced protocol was undertaken in Tartu
based on 30 forensic autopsies of men aged 40-54 years.
Simultaneously questionnaire was developed that could
be used to obtain information about the deceased from
proxy informants. This instrument was adapted from
earlier work in Russia, where this approach had been
tested extensively, including comparisons with externally
verifiable information from other sources [13]. The
questionnaire was piloted on 10 proxy informants. Fol-
lowing these pilot studies, revisions were made to the
protocol and study instruments before they were
employed in the main study. The final version of the
questionnaire was developed in Estonian together with a
Russian version, as respondents were interviewed in
their mother tongue which could be either language.
Main study protocol
Target population
The study target population was all deaths in Estonia
subject to forensic autopsy of men aged 25-54 years. For
logistical reasons, the interview study was restricted to
the subset of men who lived in or near one of the coun-
try’s five main cities: Tallinn, Tartu, Pärnu, Kohtla-Järve
and Narva.
Autopsy process
The enhanced protocol was implemented within the
context of the routine work of the forensic service.
Information sheets that set out inclusion criteria and
information about taking and managing samples were
posted on the walls of mortuaries in the four Regional
Forensic Departments. Pre-prepared collection packs
were assembled and distributed to each department.
Each pack contained a copy of the enhanced autopsy
protocol, data collection proforma and sample contain-
ers, each labelled with a unique bar code. The samples
from outlying departments were dispatched to Tartu
after the autopsy (see below) where they were processed.
Completed autopsy protocols from which the name of
the deceased was removed were sent to Tartu and
checked by one of the authors (MV), a senior forensic
pathologist.
Information collected at autopsy
The autopsy protocol was completed retrospectively by
the forensic specialist who had undertaken the autopsy.
A summary of the types of information collected is
shown in Table 1.
Cause of death
The underlying cause of death, and up to three asso-
ciated causes of death as determined by the forensic
pathologist was recorded and coded according to the
10th revision of the International Classification of Dis-
eases (ICD-10). At the point of determining cause of
death, in most cases the only information regarding
alcohol consumption of the deceased was based on evi-
dence of alcohol-induced pathology found at autopsy,
and alcohol concentrations of blood and urine. These
latter laboratory results are sometimes only available
after the cause of death was first determined. If these
results were contrary to what was initially assumed, this
would then lead to revision of the cause of death. An
example of this might be where a diagnosis of sudden
cardiac death might be revised to acute alcohol poison-
ing if the blood or urine alcohol concentrations came
back above the threshold considered as lethal. The
detailed results of the novel biomarker assays and proxy
interviews collected for this study were not available to
the forensic pathologist.
Biological samples
Blood was collected from peripheral vessels, usually the
femoral vein, using a syringe and injected into vacutai-
ner tubes (two 10-mL EDTA and one 10-mL plain).
Urine was taken directly from the bladder with a syr-
inge. Vitreous humor was aspirated from both eyes
using a syringe. A sample of renal tissue (~50 g) was
taken to provide a source of DNA for future studies.
Samples were initially refrigerated at 4°C before being
transferred to the forensic laboratory in Tartu for
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processing and analysis. Samples from locations outside
Tartu were transported there in ice-packed cold boxes,
normally arriving within 15 h.
In Tartu, one EDTA and one plain tube were centri-
fuged (2100 rpm) for 15 min at 4°C and the plasma and
serum collected. According to the amount of material
available up to eight bar-coded cryotubes were filled for
each case: two each with whole blood, plasma, serum
and urine. One cryotube of each specimen was stored at
-80°C to provide a resource for further analysis. The
renal tissue samples were stored at -20°C.
Urine and whole blood samples were sent on dry ice
to the Karolinska Institutet, Stockholm for analysis of
novel alcohol biomarkers that in live subjects have been
shown to reliably detect moderate or heavy alcohol con-
sumption up to several weeks previously. However, as
these assays were labour intensive and time consuming,
only a subset of samples were sent. As we wished to see
what these biomarkers added to post-mortem measures
of ethanol, we sent the 245 blood samples and 142
urines for subjects where blood or urine ethanol con-
centrations had been determined and a vitreous humour
sample obtained.
Laboratory assays
Urine and blood alcohol concentrations (BAC) were
measured in Tartu by headspace gas chromatography.
To detect evidence of liver damage, serum aspartate
aminotransferase (AST), alanine aminotransferase (ALT)
and gamma-glutamyl transferase (GGT) activities were
also measured. ALT and AST were measured using the
kinetic photometric method and GGT with the kinetic
colorimetric method in a Hitachi 2000. The reference
values (for live persons) are as follows: ALT < 41 U/L,
AST < 38 U/L and GGT < 61 U/L [17].
Table 1 Information collected at autopsy
General
Identifiers study number, forensic autopsy protocol number;
Time date and time of death, date and time of autopsy, date and time blood sample taken;
Macroscopic examination of
organs
Heart weight, length, breadth, depth, thickness of left and right ventricular walls, thickness of intraventricular septum;
evidence of acute infarction and/or old infarction, other gross cardiac anomaly, atheromatous occlusion of
coronary arteries, appearance of coronary arteries, thrombus of coronary arteries, other cardiovascular system;
Kidneys renal disease;
Lungs pneumonia, aspiration of gastric contents, active tuberculosis, healed tuberculosis with scarring, other (specify);
Liver weight, length, right and left lobe height and depth;
fatty liver (focal and diffuse), fibrosis, cirrhosis, other (specify);
Pancreas acute and chronic pancreatitis, other (specify);
Oesophagus, stomach and
duodenum
gastritis, gastric ulcer, duodenitis, duodenal ulcer, oesophageal varicosities, oesophagitis, other (specify);
Brain weight;
haemorrhage, infarction, new contusions, old brain trauma, cortical atrophy, cerebellar atrophy, other (specify);
Laboratory investigations
Ethanol concentration alcohol concentration in blood, vitreous humour and urine
Ethanol biomarkers (subset
only)
Phosphatidylethanol (PEth) in blood, ethyl glucronide (EtG) and ethyl sulphate (EtS) in urine
Other alcohols and ethanol
substitutes
methanol, isopropanol, isobutanol, isoamyl alcohol, ethylene glycol in blood and urine;
Drugs morphine, fentanyl, marijuana, amphetamine, cocaine, buprenorphine, methadone, other (specify);
Liver enzymes gamma-glutamyl transferase (GGT), alanine and aspartine aminotransferase (ALT and AST);
Histology
Heart right and left ventriculum and atrium, septum intraventricularis;
Coronary artery tissue sample taken in case of thrombosis;
Liver right and left lobe;
Pancreas parenchyma, any lesion;
Brain cortex, cerebellum, basal ganglia, mamiliary bodies;
Kidneys right, left;
Lung parenchyma, any lesion;
Stomach and duodenum lesion;
Cause of death immediate, intermediate, underlying, external, other important diseases, all coded to ICD-10; manner of death.
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Several alcohol biomarkers were measured at the Kar-
olinska Institutet. Whole blood phosphatidylethanol
(PEth) is a test for moderate to heavy alcohol consump-
tion over the past ~1-3 weeks and is determined by
combined liquid chromatography and mass spectrome-
try (LC-MS) [18]. Urine ethyl glycuronide (EtG) and
ethyl sulphate (EtS) [19] are conjugated minor ethanol
metabolites used to indicate consumption of alcohol in
the past ~1-2 days, also determined by LC-MS [20].
These biomarkers have the added advantage of not
being affected by the extensive genetic variation in the
main ethanol metabolism pathways. The limits of quan-
titation (LLOQ) used to indicate a positive test result
were 0.1 μmol/L for total PEth, 0.5 mg/L for EtG and
0.1 mg/L for EtS. For total PEth, a cutoff at 0.7 μmol/L
is used to distinguish moderate from excessive drinking
[21]. It had also been intended to measure serum carbo-
hydrate-deficient transferrin (CDT), a biomarker of
heavy alcohol consumption over recent weeks, but this
was not possible because of the high prevalence of hae-
molysis of the serum samples that would have interfered
with the analyis [22].
Urine samples were screened in Tartu for narcotics,
using a rapid urine test (Multiscreen 10 MTD; Biomedi-
cal Diagnostics). The LLOQ used to indicate a positive
test result were 1000 ng/mL for amphetamine, metham-
phetamine and tricyclic antidepressants, 300 ng/mL for
cocaine, opiates, methadone, barbiturates and benzodia-
zepines, 50 ng/mL for Δ- tetrahydrocannabinole, 500
ng/mL for ecstasy and 10 ng/mL for buprenorphine.
Where screening results were positive, further confirma-
tory analysis was undertaken using combined gas chro-
matography and mass spectrometry (GC-MS).
Interview study
Within two weeks of the forensic autopsy protocols and
samples arriving in Tartu, details of next-of-kin were
sought from the forensic departments. After a minimum
of two months following the death (an interval deter-
mined by cultural norms concerning the period of
mourning) the deceased’s next-of-kin were contacted.
Following a brief explanation about the study, they were
asked if they, or someone else would be willing to be
interviewed about the deceased’s life. In order to maxi-
mise the validity of the information provided, pre-
defined criteria were used to select the best informant
when several were available. If the next-of-kin was not
the best proxy, or refused to be interviewed, contact was
then made with another proxy. Those who had had
daily contact with the deceased during his last year of
life were preferred. In addition, a priority list was used
to select the person likely to have the most intimate
knowledge of the deceased’s life. This was based on
their formal relationship, which in declining order of
preference was the widow or partner of the deceased,
sister (over 18 years), mother, brother (over 18 years),
father, child (over 18 years) or finally other. Once agree-
ment and signed consent was obtained an interview
with the selected proxy was undertaken by a trained
researcher.
Information collected at interview
The interview questionnaire focussed on collecting
information on the socio-demographic characteristics
and health behaviours of the deceased, as summarised
in Table 2. Particularly detailed information was col-
lected about alcohol consumption, with a reference per-
iod of the year preceding the man’s death.
Data entry and processing
Data from the autopsy protocols and questionnaires
were double-entered and range and consistency checks
conducted.
Statistical analysis
Descriptive statistics were mainly presented as frequency
tables. Medians with interquartile ranges (IQR) or
ranges were used for presenting the results of biomar-
kers. Fisher or chi-squared test was used for assessing
the association between different characteristics (age,
cause of death, BAC) and inclusion/exclusion to the
study or whether a proxy interview was obtained. Com-
paring biomarker levels between different proxy-
reported alcohol drinking frequencies, t-test or linear
regression was used with log transformed biomarker
values. The data were analysed using the statistical pack-
age Stata 10 [23].
Ethical approval and data protection
The study was approved by the Ethics Review Commit-
tee on Human Research at the University of Tartu, Esto-
nia (No. 154/22, 20.11.2006) and the processes for
handling personal data were registered with the Estonian
Data Protection Inspection. The study was undertaken
with the full support of the Estonian Forensic Science
Institute that has sole statutory responsibility for foren-
sic autopsies in Estonia.
Results
All four Regional Forensic Departments in Estonia parti-
cipated in the study. During the study period (15 Janu-
ary 2008-11 September 2009), 3427 autopsies were
performed by the Estonian Forensic Science Institute,
2670 (77.9%) of which were male. Of these, 1299 sub-
jects were initially determined to be within the desig-
nated age range of 25-54 years. The selection of subjects
into the study is shown in Figure 1.
The aim was to include all consecutive eligible autop-
sies in the study. However, due to periodic high routine
workload, only a subset of 605 of the total of 1299 eligi-
ble autopsies were included. Following initial inclusion,
8 deaths were found to be outside the designated age
range and the identity of a further two could not be
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established. The final recruitment rate was thus 46%
(595/1299).
The characteristics of the forensic autopsies included
and excluded from the study are compared in Table 3.
As expected, due to workload of the forensic specialist
being the primary driver for exclusion, there were no
significant differences with regard to age group. How-
ever, there were slightly more deaths from external
causes and with high blood alcohol concentrations
among those included.
Cause of death
The distribution of included deaths by underlying cause
of death is shown in Table 4. By far the largest single
group of deaths by chapter were those attributed to
external causes which accounted for two-thirds of the
total. Of these, suicides and poisoning with alcohol or
other substances each constituted a quarter. Deaths due
to diseases of the circulatory system comprised nearly
one in five of all deaths, of which ischaemic heart disease
was the major single component. Alcoholic liver disease
accounted for most of the deaths of from diseases of the
digestive system. There was variation by cause in the pro-
portion of deaths where BAC levels of ≥ 0.2 mg/g were
detected: 34% circulatory diseases, 33% digestive diseases,
67% external causes, 11% other diseases and 63% of
unknown causes, although the latter two percentages are
based on particularly small numbers.
Biomarkers
The numbers of deaths for which each alcohol-related
biomarker were measured are shown in Table 5. Of the
595 deaths included, blood samples were obtained for
564 (94.8%) and urine samples for 437 (73.4%). How-
ever, the number of usable serum samples obtained
(365, 61.3%) was smaller than the total number of blood
samples taken because the blood was haemolysed or
putrefied or in some other way unusable. All tests gave
results with very wide ranges, but the medians were
considerably higher than the corresponding reference
intervals and a large proportion tested positive for
recent drinking.
Table 2 Information collected at interview
General information Information recorded
Respondent Age, date of birth, place of birth, nationality, marital status, number of children, education, profession,
views about his/her area of residence;
The deceased and
his family at time of
death
Composition and structure of household, description of the home of the subject (number of rooms,
amenities, properties), economic situation and income of the household, whether/when his parents had
died;
Relationship of res-
pondent to deceased
Relationship to the subject, duration and capacity of knowing the subject (special reference of knowing
him in the last year before his death);
Subject Age, date of birth, place of birth, nationality, marital status, number of children, education, profession, the
main reason for ceasing regular paid employment (if applicable);
History of serving in the army, serving in a zone of conflict, having been to prison;
Relations in the family, having close friends, being involved in physical fights during the last year,
diseases and disabilities (special reference in the last year before his death), persistent large changes in
the subject’s circumstances and/or behaviour (diet, exercise, drinking, smoking) that have occurred
because of ill health or disability;
Duration and pattern of smoking if applicable;
Questions regarding drinking of
alcohol by the subject
Information recorded
Frequency and
amount of drinking
Frequency and days of week of drinking beer, wine, spirits, surrogates, homemade samogon, alcoholic
coctails;
Usual and maximum amount of beer, wine, spirits, surrogates, homemade samogon, alcoholic coctails
drunk on one occasion (special reference to drinking during the last year before his death);
Indication of
hazardous drinking
Drinking spirits together with either beer or wine at the same sitting, drinking large quantities of spirits
without also eating some food at the same sitting, frequency of becoming excessively drunk/having
hangover, drinking alcohol before noon, frequency of failing to fulfil his family or personal or work
obligations due to drinking alcohol, going to sleep at night with his clothes on because of being drunk,
drinking alone, frequency and duration of zapoi, being arrested because he was drunk, drinking
surrogates;
Other alcohol
questions
Distance of get to the nearest place where one can buy beverages, being admitted to hospital/clinic
because of alcohol poisoning, having had help or advice from a doctor, narcologist, social worker or
some other professional for an alcohol problem, subject’s father when the subject was growing up or
anyone in the subject’s household apart from him going on zapoi;
Surrogates Main reason and time of start of drinking surrogates, drinking surrogates at home, types and amount of
surrogates drunk, subject’s father when the subject was growing up or anyone in the subject’s
household apart from him drinking surrogates;
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???? ???? ???? ????
Total number of men 
autopsied, all ages 
(N=2670) 
Number of men autopsied 
initially considered 25–54 
years (N=1299)
Number of men initially 
considered aged 25–54 
years included in study 
Number of men 
aged 25–54 years eligible ???? ???? ???? ????
Total number of autopsied men 
aged 25–54 years in the study 
N=595 
Figure 1 Selection of study subjects by Regional Forensic Departments (RFD) of the Estonian Forensic Science Institute. All four
Regional Forensic Departments in Estonia participated in the study. During the study period (15 January 2008-11 September 2009), 3427
autopsies were performed by the Estonian Forensic Science Institute, 2670 (77.9%) of which were male. Of these, 1299 subjects were initially
determined to be within the designated age range of 25-54 years.
Table 3 Characteristics of eligible deaths included and excluded from the study
Characteristics Included Excluded
Number % Number % P value*
Age (years) 0.416
25-34 144 24.2 186 26.4
35-44 159 26.7 198 28.1
45-54 292 49.1 320 45.5
Underlying cause of death** 0.001
Diseases 184 30.9 205 29.1
Circulatory system (I00-I99) 101 54.9 103 50.2
Digestive system (K00-K99) 54 29.3 63 30.7 0.591
Other diseases 29 15.8 39 19.0
Unknown causes (R95-R99) 16 2.7 50 7.1
External causes (V01-Y98) 395 66.4 449 63.8
Blood alcohol concentration (BAC) 0.013
No 31 5.2 63 8.9
Yes 564 94.8 641 91.1
BAC < 0.2 mg/g 254 45.0 354 55.2 < 0.001
BAC ≥ 0.2 mg/g 310 55.0 287 44.8
Total 595 100 704 100
* Comparing distribution of different characteristics between deaths included and excluded from the study using chi-squared test
** As coded by the forensic specialist following autopsy
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About 80% of the whole blood samples and urines
examined tested positive for total PEth (> 0.7 mlL and
EtG/EtS, respectively. It should be noted that some of
the PEth values were considerably higher than those
observed in studies of chronic heavy drinkers [18]. In
fact 28% of the blood samples showed total PEth values
of 22 μmol/L or above, with 4.5% greater than 50 μmol/
L, suggesting post-mortem formation [18].
Proxy informant interviews
The process of selection of subjects for proxy informant
interview is shown in Figure 2. Of 276 deceased men
eligible for inclusion because they lived in one of the 5
major towns in Estonia, for 7% it was not possible to
find out whether they had had a family as their bodies
were either collected by the funeral agency or their fun-
eral was organised by the local authorities. Of those for
whom it was possible to determine whether they had a
family, 7% had no family (lived alone). Of the remaining
239 deceased men, 226 had families eligible for inter-
view, i.e. at least one family member had had daily
contact with the deceased during the last year before his
death. Of these, a proxy interview was conducted for
169 (75%), the remainder either refusing (20%) or did
not respond (5%), resulting in a response rate of 61%
(169/276). The distribution of the relationship of the
proxy to the subject was wife/girlfriend/partner (n = 47)
and parent (n = 46; 35 mothers and 11 fathers), sister (n
Table 4 Distribution of deaths included in the study by underlying cause of death*
Cause of death by major groups (ICD-10 code) Number %
Diseases 184 30.9
Circulatory system (I00-I99) 101 54.9
Ischaemic heart diseases (I20-I25) 42 41.6
Alcoholic cardiomyopathy (I42.6) 3 3.0
Cardiomyopathy (I42, excl I42.6) 6 5.9
Cerebrovascular diseases (I60-I69) 14 13.9
Other diseases of the circulatory system 36 35.6
Digestive system (K00-K99) 54 29.3
Alcoholic liver disease (K70) 44 81.5
Cirrhosis and fibrosis (K74) 1 1.9
Other diseases of the digestive system 9 16.7
Other diseases 29 15.8
Unknown causes (R95-R99) 16 2.7
External causes (V01-Y98) 395 66.4
Transport Accidents (V01-V99) 38 9.6
Falls (W00-W19) 23 5.8
Accidental drowning and submersion (W65-W74) 28 7.1
Inhalation of gastric contents or food causing obstruction 34 8.6
of respiratory tract (W78-W79)
Alcohol poisoning (X45) 45 11.4
Accidental poisoning by and exposure to noxious 53 13.4
substances (X40-X49, excl X45)
Intentional self-harm (X60-X84) 101 25.6
Assault (X85-Y09) 30 7.6
Exposure to excessive natural cold (X31) 10 2.5
Event of undetermined intent (Y10-Y34) 20 5.1
Other external causes 13 3.3
Total 595 100
* As coded by the forensic specialist following autopsy
Table 5 Alcohol biomarker availability and levels
Biomarker, units Number % of all
autopsies
(N = 595)
Median Range
Ethanol (blood), mg/g 564 94.8 0.78 0-6.59
Ethanol (urine), mg/g 437 73.4 1.51 0-6.14
AST (serum), U/L 364 61.2 1014 59-28790
ALT (serum), U/L 364 61.2 792 8-42580
GGT (serum), U/L 365 61.3 92 15-1884
PEth (blood), μmol/L 245 42.2 9.8 0-121.5
EtG (urine), mg/L 157 26.4 79 0-2699
EtS (urine), mg/L 157 26.4 22 0-480
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= 16), other close relative (n = 12), other companion (n
= 12), brother (n = 11), son (n = 11), daughter (n = 7),
friend (n = 7).
The characteristics of those deaths where a proxy
interview was obtained are compared in Table 6. Those
for whom a proxy interview was obtained were less
likely to have died from diseases of the digestive system.
In addition, those deaths for whom a proxy interview
was obtained were less likely to have a BAC ≥ 0.2 mg/g
than those where a proxy was not interviewed.
Socio-demographic and behavioural characteristics of
subjects
The characteristics of the deceased men, based on infor-
mation provided by a proxy informant, are shown in
Table 7. Over half the deceased men with proxy inter-
views were of non-Estonian nationality (mainly Russian),
a half were separated, divorced or had never been
married, while just under a half were in a regular paid
job. The proxy reported prevalence of drinking at all in
the past year was 84% and in the past month 54%, with
over a quarter of men reported to have been drinking
daily or almost daily in the year before death. One in 10
of the deceased were reported by proxies to have drunk
non-beverage alcohols at least several times in the year
before death.
Alcohol biomarkers and proxy reported drinking
Median values of the various alcohol biomarkers by
proxy reported drinking behaviour are shown in Table
8. Median blood alcohol concentration was only raised
substantially among daily drinkers, consistent with its
rapid disappearance from the body. However, a more
graded association was apparent for the novel biomar-
kers PEth in whole blood and EtS and EtG in urine,
with negative or very low levels in reported abstainers.
Total number of autopsied men who 
lived in one of 5 major towns 
276
Existence of family not known
19 
Family not 
eligible 
13 
Did not respond 
to contact 
attempts 
11 
Interview 
conducted 
169 
No 
18 
Family 
eligible 
226 
Refused 
46 
Yes 
239 
Existence of family known
257 
Figure 2 Flow chart of subjects for proxy informant interview. Of 276 deceased men eligible for inclusion because they lived in one of the
5 major towns in Estonia, for 7% it was not possible to find out whether they had had a family as their bodies were either collected by the
funeral agency or their funeral was organised by the local authorities. Of those for whom it was possible to determine whether they had a
family, 7% had no family (lived alone). Of the remaining 239 deceased men, 95% had families eligible for interview, i.e. at least one family
member had had daily contact with the deceased during the last year before his death. Of these, a proxy interview was conducted for 75%,
while 20% of families refused, and 5% did not respond to contact attempts. Overall we obtained proxy interviews for 61% (169/276) of all
eligible deceased men, representing 75% of all where we knew that there were eligible proxy informants (169/226).
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However, for a proportion of subjects where the proxy
reported that the man had not drunk in the last month
the biomarkers were clearly positive, suggesting proxy
underreporting. The liver enzymes AST and ALT dis-
play a very wide range, consistent with a variable degree
of post mortem haemolysis and autolysis of hepatocytes
and, for AST, myocytes. In contrast, there was a signifi-
cant association between frequency of drinking alcohol
and GGT, although this was mainly due to elevated
levels among daily drinkers.
Discussion and Conclusion
This study provides a unique resource for studying the
existence of pathologies detected at forensic autopsy
with particular emphasis upon the role of recent and
chronic alcohol drinking in a country with a high level
of hazardous drinking. These first results have shown
that several of the novel alcohol biomarkers appear to
perform well in post-mortem samples, and could be
more widely used in other autopsy studies particularly
in the absence of proxy-reported alcohol consumption
patterns.
A major strength of this study is the systematic col-
lection of information about the presence/absence of
other pathologies of interest, regardless of whether or
not they were considered to have contributed to the
death. This goes considerably beyond what would be
recorded routinely at forensic autopsy. A further
strength is the systematic collection of proxy informa-
tion about the deceased. However, the most unique
feature of the study is the information on a wide range
of informative alcohol biomarkers, several of which
have not been used previously in this sort of post-mor-
tem research study. The main weakness of the study is
that it is restricted to deaths subject to forensic
autopsy. These are a highly selected subset of all
deaths, and thus cannot be used as a basis for estimat-
ing the overall burden of alcohol-related mortality.
Furthermore, it is necessary to be aware of the poten-
tial for bias (such as recall and social acceptability) in
the proxy interviews. Nevertheless, this sort of study
can provide insights into the coexistence of multiple
pathologies, and their relationship to patterns and
levels of alcohol consumption.
One of the striking substantive findings is that over
half of the deaths for whom proxy interviews were con-
ducted were of men of non-Estonian (mainly Russian)
ethnicity. This is a far higher proportion than seen in
the national mortality data for men of working age,
although it may partially reflect the fact that they are
more likely to live in towns. However, we do know that
non-Estonians have a higher mortality than Estonians
for almost all causes of death in Estonia [24], and espe-
cially alcohol-related causes [25,26], consistent with
known differences in binge [4] and surrogate drinking
[7].
Table 6 Characteristics of deaths in the study and eligible* to be interviewed according to whether a proxy interview
was obtained
Characteristics Included Excluded
Number % Number % P value**
Age (years) 0.291
25-34 50 29.6 29 27.1
35-44 35 20.7 31 29.0
45-54 84 49.7 47 43.9
Underlying cause of death 0.769
Diseases 70 41.4 40 37.4
Circulatory system (I00-I99) 41 58.6 21 52.5
Digestive system (K00-K99) 10 14.3 16 40.0 0.002
Other diseases 19 27.1 3 7.5
Unknown causes (R95-R99) 4 2.4 2 1.9
External causes (V01-Y98) 95 56.2 65 60.7
Blood alcohol concentration (BAC) 0.788
measured
No 8 4.7 5 4.7
Yes 161 95.3 102 95.3
BAC < 0.2 mg/g 89 55.3 49 48.0 < 0.001
BAC ≥ 0.2 mg/g 72 44.7 53 52.0
Total 169 100 107 100
*Only for deaths to men resident in and around one of the five major towns attempts were made to undertake proxy interview
**Comparing distribution of different characteristics between deaths included and excluded from the study using chi-squared or Fisher test
Ringmets et al. BMC Public Health 2012, 12:146
http://www.biomedcentral.com/1471-2458/12/146
Page 10 of 14
Table 7 The characteristics of the deceased men based on information provided by a proxy informant
Characteristics Number %
Age group (years)
25-34 50 29.6
35-44 35 20.7
45-54 84 49.7
Nationality
Estonian 68 40.2
Russian 86 50.9
Other 15 8.9
Marital status before death
Living with wife in registered marriage 45 26.6
Living with partner not in registered marriage 33 19.5
Divorced or living separately 42 24.9
Widowed 4 2.4
Never been married 45 26.6
Employment status
In a regularly paid job 78 46.2
In a temporary job 26 15.4
Unemployed, looking for job 23 13.6
Unemployed, not looking for job 19 11.2
Unemployed and disability pension 12 7.1
Disability pension (incl 1 retired person) 11 6.5
Drank alcohol (of any type including surrogates) several
times or more in the year before death*
Yes 142 84.0
No 18 10.7
Do not know 9 5.3
Drank alcohol (of any type including surrogates) several
times or more in the month before death *
Yes 84 53.8
No 45 28.8
Do not know 22 14.1
Missing answer 5 3.2
Frequency of drinking any alcohol during last year
Every day/almost every day 48 28.4
1-4 times per week 47 27.8
3 times per month or less frequently 47 27.8
Never/almost never 18 10.7
Do not know 9 5.3
Drank surrogates several times or more in the year
before death
Yes 18 10.7
No 127 75.1
Do not know 21 12.4
Missing answer 3 1.8
Smoking status at death
Smoker 132 78.1
Ex-smoker 15 8.9
Never smoked 22 13.0
Total 169 100
*This question was asked when deceased man was ever drunk alcohol in his life at least a few occasions (N = 156)
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How do the results reported here compare to those
from other autopsy studies? In a series of consecutive
routine medico-legal autopsies in Norway 1973-1992
[27], 47.6% of autopsies had a BAC ≥ 0.5 mg/g. In our
study, 55% of autopsies had a BAC ≥ 02 mg/g, which is
the legal limit for driving a vehicle in Estonia [28].
This study substantially extends our understanding of
the potential use of alcohol-related biomarkers at
autopsy. We already know that liver enzymes, used
widely to detect liver damage in living subjects, are of
limited value post mortem. AST and ALT are increased
by haemolysis and hypoxia and so are subject to differ-
ences in the process of dying. In contrast, GGT, as a
marker of liver fibrosis and cirrhosis, is less affected by
these processes.
Notably, PEth in blood, and EtG and EtS in urine all
had zero or very low levels among the never/almost
never drinking category. This indicates a high specificity
of the novel alcohol biomarkers even in an autopsy set-
ting. Nevertheless, the risk of post-mortem elevation
needs to be carefully considered when interpreting
values of PEth in post-mortem toxicology, given that
some extremely high results were observed. Artefactual
elevation of PEth levels may be due to ethanol produced
by post-mortem fermentation in those who have not
been drinking prior to death, and/or during storage in
samples where the blood alcohol concentration at death
was high [18].
EtG and EtS are conjugated ethanol metabolites. We
have demonstrated [29,30] that EtG is sensitive to
Table 8 Biomarker levels (median and inter-quartile range (IQR) for proxy-reported alcohol drinking behaviour
Alcohol drinking
behaviour of subject
before death
Biomarker
Ethanol
(blood)
mg/g
Ethanol (urine)
mg/g
AST (serum)
U/L
ALT (serum)
U/L
GGT (serum)
U/L
PEth
(blood)
μmol/L
EtG (urine)
mg/L
EtS
(urine)
mg/L
N Median
(IQR)
N Median
(IQR)
N Median
(IQR)
N Median
(IQR)
N Median
(IQR)
N Median
(IQR)
N Median
(IQR)
N Median
(IQR)
Frequency of drinking any alcohol during last year
Every day /
almost every day
45 0.63
(0-2.0)
30 0.7
(0-2.9)
29 1558
(562-
3210)
29 929
(237-
2725)
29 193
(116-
526)
44 9.7
(4.1-19.7)
26 78.3
(4.6-179)
26 23.1
(0-439)
1-4 times per
week
46 0
(0-2.1)
40 0.6
(0-3.4)
30 972
(551-
1573)
30 985
(355-
2618)
30 69
(49-122)
38 8.7
(2.6-16.1)
33 43.4
(4.3-
246.9)
33 23.0
(0.09-
350)
3 times per month
or more rarely
45 0
(0-2.1)
37 0
(0-2.2)
33 874
(467-
2210)
33 910
(258-
4675)
33 77
(62-111)
41 5.1
(0.5-19.0)
31 41.7
(0.2-338)
31 8.4
(0-198)
Never / almost
never
16 0
(0-0)
10 0
(0-0)
11 1686
(895-
2384)
11 1856
(1393-
3319)
11 69
(30-172)
11 0
(0-0.4)
4 0.1
(0-0.2)
4 0.01
(0-0.15)
P value for trend* 0.041 0.080 0.897 0.237 < 0.001 < 0.001 0.046 0.038
Drinking any alcohol during last month
Yes 80 0.2
(0-2.2)
58 0.6
(0-3.4)
54 1114
(634-
3119)
54 988
(466-
2940)
54 92
(57-168)
66 10.8
(4.3-22.9)
49 94.6
(4.6-338)
49 23.0
(1.1-69)
No 44 0
(0-2.0)
34 0
(0-2.2)
26 896
(399-
1779)
26 885
(174-
2725)
26 96
(66-172)
41 3.9
(0.2-10.3)
29 37.3
(0.3-
172.2)
29 8.4
(0.1-49.8)
P value** 0.675 0.373 0.166 0.399 0.962 0.001 0.180 0.224
Drinking surrogates during last year
Yes 16 0.3
(0-1.8)
11 0
(0-3.1)
11 1558
(283-
6208)
11 1031
(237-
1951)
11 255
(86-511)
16 9.7
(3.4-18.5)
10 138.5
(2.7-771)
10 33.3
(0.6-98.7)
No 12
1
0
(0-2.1)
95 0
(0-2.9)
83 1036
(553-
2604)
83 1078
(359-
3810)
83 85
(52-163)
103 6.7
(1.2-15.5)
74 51.9
(2.5-
246.9)
74 12.6
(0.7-53.7)
P value** 0.912 0.553 0.922 0.202 0.010 0.362 0.349 0.355
*Regression method was applied for trend using log-values of biomarkers
**T-test was applied using log-values of biomarker
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bacterial degradation (e.g. in the presence of E. coli) but
also that EtG may be formed due to bacterial activity
when ethanol is present. In contrast, EtS is not suscepti-
ble to bacterial degradation/synthesis making it the pre-
ferable biomarker for recent drinking in post-mortem
toxicology. In routine clinical use, both metabolites are
therefore measured as was done in this study. However,
calculation of the EtG/EtS molar ratio, as an index of
EtG disappearance/formation showed similar, albeit sig-
nificantly higher values than in a Swedish clinical refer-
ence material (mean/median in the Estonian post-
mortem sample were 2.57/2.39 mg/L; in the Karolinska
reference sample 2.34/1.70 mg/L; p = 0.0064). There
was only one sample that showed a markedly different
ratio. However, this indicates that bacterial interference
between time of death and autopsy was not a major
problem in this study. Taken together, these data sug-
gest that these novel biomarkers perform well as quanti-
tative markers of the frequency of recent alcohol intake
(i.e. within ~1-3 days) in aetiological epidemiological
research. Despite this, their use in forensic legal contexts
still requires caution [31].
In summary, this paper describes a unique resource
for investigating the contribution of alcohol to prema-
ture mortality. The data are being further exploited to
look at a number of key areas: 1) a more detailed
exploration of the association between morphological
pathologies, biomarkers of alcohol consumption and
proxy reports of drinking behaviour; 2) assessment of
the association of autopsy evidence of alcohol-induced
damage and proxy reports and biomarker indicators of
high levels of alcohol consumption; 3) investigating the
association of proxy reports and biomarker indicators of
alcohol consumption with mortality from cardiovascular
conditions.
We hope that the approach that we have described
will be applied by other research groups in other set-
tings, thus helping to improve our still surprisingly lim-
ited knowledge of the post-mortem findings associated
with problematic and hazardous alcohol use.
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